Users with certain genetic profiles may tolerate dose escalation faster and experience milder, shorter-duration side effects, enabling quicker weight loss results
doi: 10.2337/dc21-1839 4. Li F, et al
It binds directly to GHRH receptors on somatotroph cells in the anterior pituitary, enhancing both the amplitude and duration of GH secretion
This systematic review has potential limitations
Anti-Actin (AA128, Beyotime), anti-GPR109a (ab81825, Abcam, USA), anti-GPR43 (DF2746, Affinity Biosciences, USA), anti-H3 (anti-total histone H3, 4499, Cell Signaling Technology, CST, USA), anti-Ace-H3 (anti-pan-acetyl histone H3, 61637, Active Motif, USA), anti-p-AMPK (2535, adenosine monophosphate activated protein kinase, CST, USA), anti-p-ACC (11818, p-acetyl-CoA carboxylase, CST), anti-IR (anti-insulin receptor, ab5500, Abcam), anti-IRS-1 (anti-insulin receptor substrate-1, ab46800, Abcam), and anti-GLP-1R (NBP1-97308, Novus Biologicals, USA) were used in our study
These medications work by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
